These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Rhinitis medicamentosa. Black MJ; Remsen KA Can Med Assoc J; 1980 Apr; 122(8):881-4. PubMed ID: 6154514 [TBL] [Abstract][Full Text] [Related]
48. Effect on the nasal mucosa of long-term treatment with oxymetazoline, benzalkonium chloride, and placebo nasal sprays. Graf P; Hallén H Laryngoscope; 1996 May; 106(5 Pt 1):605-9. PubMed ID: 8628089 [TBL] [Abstract][Full Text] [Related]
49. Decongestion effect and rebound swelling of the nasal mucosa during 4-week use of oxymetazoline. Graf P; Juto JE ORL J Otorhinolaryngol Relat Spec; 1994; 56(3):157-60. PubMed ID: 7515487 [TBL] [Abstract][Full Text] [Related]
50. Correlation between objective nasal mucosal swelling and estimated stuffiness during long-term use of vasoconstrictors. Graf P; Juto JE ORL J Otorhinolaryngol Relat Spec; 1994; 56(6):334-9. PubMed ID: 7530821 [TBL] [Abstract][Full Text] [Related]
54. Rhinitis medicamentosa: electron microscopic changes of human nasal mucosa. Knipping S; Holzhausen HJ; Goetze G; Riederer A; Bloching MB Otolaryngol Head Neck Surg; 2007 Jan; 136(1):57-61. PubMed ID: 17210334 [TBL] [Abstract][Full Text] [Related]
55. Predisposing factors of rhinitis medicamentosa: what can influence drug discontinuation? De Corso E; Mastrapasqua RF; Tricarico L; Settimi S; Di Cesare T; Mele DA; Trozzi L; Salonna G; Paludetti G; Galli J Rhinology; 2020 Jun; 58(3):233-240. PubMed ID: 31904029 [TBL] [Abstract][Full Text] [Related]